H2AJ and central nervous system cancer: Whereas H2AFJ knockdown sensitized D54MG glioma cells to TMZ treatment (Figure 3E), H2AFJ overexpression rendered T98G glioma cells more resistant to TMZ treatment (Figure 3F).